ADMA logo

ADMA Biologics (ADMA) Non Current Assets

Annual Non Current Assets

$72.17 M
-$5.89 M-7.55%

31 December 2023

ADMA Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Non Current Assets

$72.42 M
-$283.00 K-0.39%

30 September 2024

ADMA Quarterly Non Current Assets Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ADMA Non Current Assets Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-7.5%-3.8%
3 y3 years+33.8%+13.4%
5 y5 years+62.7%+79.0%

ADMA Non Current Assets High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-7.5%+33.8%-7.2%+13.4%
5 y5 years-7.5%+74.9%-7.2%+79.0%
alltimeall time-7.5%-7.2%

ADMA Biologics Non Current Assets History

DateAnnualQuarterly
Sept 2024
-
$72.42 M(-0.4%)
June 2024
-
$72.71 M(-2.3%)
Mar 2024
-
$74.46 M(+3.2%)
Dec 2023
$257.01 M(-5.0%)
$72.17 M(-4.2%)
Sept 2023
-
$75.30 M(-1.9%)
June 2023
-
$76.78 M(+0.1%)
Mar 2023
-
$76.70 M(-1.7%)
Dec 2022
$270.40 M(+29.5%)
$78.06 M(+2.1%)
Sept 2022
-
$76.46 M(+3.1%)
June 2022
-
$74.16 M(+8.7%)
Mar 2022
-
$68.23 M(+1.0%)
Dec 2021
$208.73 M(+35.8%)
$67.52 M(+5.7%)
Sept 2021
-
$63.86 M(+3.9%)
June 2021
-
$61.46 M(+5.3%)
Mar 2021
-
$58.39 M(+8.3%)
Dec 2020
$153.74 M(+79.1%)
$53.93 M(+7.0%)
Sept 2020
-
$50.43 M(+3.9%)
June 2020
-
$48.55 M(+7.8%)
Mar 2020
-
$45.04 M(+9.1%)
Dec 2019
$85.82 M(+92.7%)
$41.27 M(+2.0%)
Sept 2019
-
$40.46 M(+2.7%)
June 2019
-
$39.39 M(-1.0%)
Mar 2019
-
$39.79 M(-10.3%)
Dec 2018
$44.53 M(-28.6%)
$44.35 M(+1.2%)
Sept 2018
-
$43.84 M(-0.6%)
June 2018
-
$44.12 M(-1.3%)
Mar 2018
-
$44.72 M(-2.1%)
Dec 2017
$62.34 M
$45.68 M(+10.4%)
Sept 2017
-
$41.37 M(+2.5%)
DateAnnualQuarterly
June 2017
-
$40.37 M(+2011.6%)
Mar 2017
-
$1.91 M(-5.7%)
Dec 2016
$21.66 M(+1.7%)
$2.03 M(-5.1%)
Sept 2016
-
$2.14 M(-5.0%)
June 2016
-
$2.25 M(-3.4%)
Mar 2016
-
$2.33 M(-4.0%)
Dec 2015
$21.29 M(-11.6%)
$2.42 M(-6.2%)
Sept 2015
-
$2.58 M(-3.3%)
June 2015
-
$2.67 M(-9.3%)
Mar 2015
-
$2.95 M(+0.3%)
Dec 2014
$24.09 M(-22.4%)
$2.94 M(+8.1%)
Sept 2014
-
$2.72 M(+95.5%)
June 2014
-
$1.39 M(+19.4%)
Mar 2014
-
$1.16 M(+25.5%)
Dec 2013
$31.05 M(+122.6%)
$927.50 K(-40.5%)
Sept 2013
-
$1.56 M(+2.7%)
June 2013
-
$1.52 M(+0.4%)
Mar 2013
-
$1.51 M(-5.9%)
Dec 2012
$13.95 M(>+9900.0%)
$1.61 M(+29.3%)
Sept 2012
-
$1.24 M(-1.7%)
June 2012
-
$1.26 M(+8.6%)
Mar 2012
-
$1.16 M(>+9900.0%)
Dec 2011
-
$0.00(0.0%)
Sept 2011
-
$0.00(0.0%)
June 2011
$8500.00(-29.2%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
Dec 2010
-
$0.00(0.0%)
June 2010
-
$0.00
June 2010
$12.00 K
-

FAQ

  • What is ADMA Biologics annual long term assets?
  • What is the all time high annual non current assets for ADMA Biologics?
  • What is ADMA Biologics annual non current assets year-on-year change?
  • What is ADMA Biologics quarterly long term assets?
  • What is the all time high quarterly non current assets for ADMA Biologics?
  • What is ADMA Biologics quarterly non current assets year-on-year change?

What is ADMA Biologics annual long term assets?

The current annual non current assets of ADMA is $72.17 M

What is the all time high annual non current assets for ADMA Biologics?

ADMA Biologics all-time high annual long term assets is $78.06 M

What is ADMA Biologics annual non current assets year-on-year change?

Over the past year, ADMA annual long term assets has changed by -$5.89 M (-7.55%)

What is ADMA Biologics quarterly long term assets?

The current quarterly non current assets of ADMA is $72.42 M

What is the all time high quarterly non current assets for ADMA Biologics?

ADMA Biologics all-time high quarterly long term assets is $78.06 M

What is ADMA Biologics quarterly non current assets year-on-year change?

Over the past year, ADMA quarterly long term assets has changed by -$2.87 M (-3.81%)